サンコバ点眼液０．０２％ ５ｍＬ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00115 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 45 |
| 日本商品名（例） | サンコバ点眼液０．０２％ ５ｍＬ, サンコバ点眼液０．０２％ ５ｍＬ（選）, シアノコバラミン点眼液０．０２％「センジュ」 ５ｍＬ |
承認適応症（KEGG）
甲状腺機能亢進症、広節裂頭条虫症
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | vitamin deficiency disorder | 99% | DL |
| 2 | biotin metabolic disease | 99% | DL |
| 3 | pernicious anemia | 97% | DL |
| 4 | inborn error of biotin metabolism | 97% | DL |
| 5 | non-syndromic esophageal malformation | 97% | DL |
| 6 | inflammatory myopathy with abundant macrophages | 97% | DL |
| 7 | idiopathic eosinophilic myositis | 97% | DL |
| 8 | immune-mediated necrotizing myopathy | 97% | DL |
| 9 | antisynthetase syndrome | 97% | DL |
| 10 | proteinuria | 97% | DL |
| 11 | focal myositis | 97% | DL |
| 12 | primary CD59 deficiency | 97% | DL |
| 13 | neonatal autoimmune hemolytic anemia | 96% | DL |
| 14 | primary release disorder of platelets | 96% | DL |
| 15 | mixed-type autoimmune hemolytic anemia | 96% | DL |
| 16 | pseudo-von Willebrand disease | 96% | DL |
| 17 | drug-induced autoimmune hemolytic anemia | 96% | DL |
| 18 | cold agglutinin disease | 96% | DL |
| 19 | paroxysmal nocturnal hemoglobinuria | 96% | DL |
| 20 | Glanzmann thrombasthenia | 95% | DL |
| 21 | constitutional megaloblastic anemia due to folate metabolism disorder | 94% | DL |
| 22 | esophageal disease | 94% | DL |
| 23 | infantile digital fibromatosis | 94% | DL |
| 24 | cerebral folate deficiency | 94% | DL |
| 25 | inborn disorder of pyridoxine metabolism | 94% | DL |
| 26 | acquired amyloid peripheral neuropathy | 94% | DL |
| 27 | Ledderhose disease | 94% | DL |
| 28 | C1 inhibitor deficiency | 94% | DL |
| 29 | primary amyloidosis | 94% | DL |
| 30 | penile fibromatosis | 94% | DL |
| 31 | palmar fibromatosis | 94% | DL |
| 32 | dermis disease | 94% | DL |
| 33 | serpinopathy with toxic serpin polymerization | 94% | DL |
| 34 | nodular cutaneous amyloidosis | 92% | DL |
| 35 | macular amyloidosis | 92% | DL |
| 36 | amyloidosis cutis dyschromia | 92% | DL |
| 37 | amyloidosis (disease) | 92% | DL |
| 38 | iron deficiency anemia | 91% | DL |
| 39 | dermatomyositis | 91% | DL |
| 40 | deficiency anemia | 90% | DL |
| 41 | selective IgG immunodeficiency | 90% | DL |
| 42 | microcytic anemia | 70% | DL |
| 43 | folic acid deficiency anemia | 70% | DL |
| 44 | vitamin B12 deficiency | 65% | DL |
| 45 | hypochromic anemia | 38% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。